S Fahn

9.1k total citations · 3 hit papers
50 papers, 5.6k citations indexed

About

S Fahn is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, S Fahn has authored 50 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Neurology, 11 papers in Psychiatry and Mental health and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in S Fahn's work include Neurological disorders and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (16 papers) and Neurological and metabolic disorders (8 papers). S Fahn is often cited by papers focused on Neurological disorders and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (16 papers) and Neurological and metabolic disorders (8 papers). S Fahn collaborates with scholars based in United States, Spain and Sweden. S Fahn's co-authors include Gerald Cohen, Christopher G. Goetz, J. William Langston, David J. Brooks, Håkan Widner, Thomas B. Freeman, Ray L. Watts, Serge Przedborski, Nir Giladi and Vernice Jackson‐Lewis and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and American Journal of Clinical Nutrition.

In The Last Decade

S Fahn

49 papers receiving 5.4k citations

Hit Papers

Members of the UPDRS Development Committee. Unified Parki... 1987 2026 2000 2013 1987 1992 1992 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Fahn United States 26 4.2k 1.4k 860 855 634 50 5.6k
W R Gibb United Kingdom 29 5.2k 1.2× 1.8k 1.3× 823 1.0× 935 1.1× 1.1k 1.7× 61 6.6k
Elan D. Louis United States 49 4.1k 1.0× 1.5k 1.1× 1.1k 1.2× 909 1.1× 610 1.0× 135 6.9k
E. Martignoni Italy 41 2.8k 0.7× 1.3k 0.9× 1.3k 1.5× 733 0.9× 379 0.6× 172 6.1k
Caroline Rick United Kingdom 25 4.4k 1.1× 1.9k 1.4× 814 0.9× 1.2k 1.4× 594 0.9× 54 6.5k
Christopher G. Goetz United States 33 4.1k 1.0× 1.6k 1.2× 942 1.1× 909 1.1× 802 1.3× 102 6.3k
Claudio Pacchetti Italy 41 3.4k 0.8× 1.1k 0.8× 517 0.6× 995 1.2× 428 0.7× 135 4.8k
Giselle M. Petzinger United States 30 2.9k 0.7× 1.7k 1.3× 957 1.1× 584 0.7× 653 1.0× 76 4.7k
Ray L. Watts United States 42 4.3k 1.0× 2.1k 1.5× 485 0.6× 942 1.1× 747 1.2× 84 6.0k
Miguel Coelho Portugal 33 4.0k 1.0× 1.4k 1.0× 688 0.8× 706 0.8× 434 0.7× 103 5.3k
Martijn L.T.M. Müller United States 38 3.1k 0.7× 1.2k 0.9× 627 0.7× 1.2k 1.4× 503 0.8× 111 4.9k

Countries citing papers authored by S Fahn

Since Specialization
Citations

This map shows the geographic impact of S Fahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Fahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Fahn more than expected).

Fields of papers citing papers by S Fahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Fahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Fahn. The network helps show where S Fahn may publish in the future.

Co-authorship network of co-authors of S Fahn

This figure shows the co-authorship network connecting the top 25 collaborators of S Fahn. A scholar is included among the top collaborators of S Fahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Fahn. S Fahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Louis, Elan D., Gilberto Levy, Lucien Côté, et al.. (2001). Clinical Correlates of Action Tremor in Parkinson Disease. Archives of Neurology. 58(10). 1630–1630. 96 indexed citations
2.
Louis, Elan D., Linda Winfield, S Fahn, & Blair Ford. (2001). Speech Dysfluency Exacerbated by Levodopa in Parkinson's Disease. Movement Disorders. 16(3). 562–565. 42 indexed citations
3.
Frucht, Steven J., S Fahn, Blair Ford, & Michael H. Gelb. (1999). A geste antagoniste device to treat jaw-closing dystonia. Movement Disorders. 14(5). 883–886. 11 indexed citations
4.
Fahn, S. (1999). Parkinson Disease, the Effect of Levodopa, and the ELLDOPA Trial. Archives of Neurology. 56(5). 529–529. 182 indexed citations
5.
Tabbal, Samer D., S Fahn, & Steven J. Frucht. (1998). Fetal tissue transplanation in Parkinson’s disease. Current Opinion in Neurology. 11(4). 341–349. 30 indexed citations
7.
Fahn, S. (1997). An Overview of Novel Therapies for Parkinson's Disease. Experimental Neurology. 144(1). 21–23. 4 indexed citations
8.
Tan, Adrian Y., Miran Salgado, & S Fahn. (1996). Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Movement Disorders. 11(2). 214–216. 109 indexed citations
9.
Pardo, Beatriz, María A. Mena, S Fahn, & Justo Garcı́a de Yébenes. (1993). Ascorbic acid protects against levodopa‐induced neurotoxicity on a catecholamine‐rich human neuroblastoma cell line. Movement Disorders. 8(3). 278–284. 50 indexed citations
10.
Langston, J. William, Håkan Widner, Christopher G. Goetz, et al.. (1992). Core assessment program for intracerebral transplantations (CAPIT). Movement Disorders. 7(1). 2–13. 861 indexed citations breakdown →
11.
Fahn, S & Gerald Cohen. (1992). The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Annals of Neurology. 32(6). 804–812. 768 indexed citations breakdown →
12.
Fahn, S. (1991). An open trial of high-dosage antioxidants in early Parkinson's disease. American Journal of Clinical Nutrition. 53(1). 380S–382S. 64 indexed citations
13.
14.
Jackson‐Lewis, Vernice, et al.. (1989). Regional effects of 6-hydroxydopamine (6-OHDA) on free radical scavengers in rat brain. Brain Research. 504(1). 139–141. 52 indexed citations
15.
Bressman, Susan, et al.. (1988). Clonazepam, Haloperidol, and Clonidine in Tic Disorders. Southern Medical Journal. 81(9). 1103–1105. 23 indexed citations
16.
Defendini, R, et al.. (1988). Magnetic resonance imaging of dystonic states.. PubMed. 50. 265–75. 39 indexed citations
17.
Truong, Daniel, Justo Garcı́a de Yébenes, Gianni Pezzoli, Vernice Jackson‐Lewis, & S Fahn. (1988). Glycine involvement in DDT‐induced myoclonus. Movement Disorders. 3(1). 77–87. 8 indexed citations
18.
Fahn, S, et al.. (1985). Correlation of behavioral and biochemical parameters of dopamine d 1 and d 2 receptor activation. Journal of Neurology. 232. 107. 2 indexed citations
19.
Ilson, Joyce, et al.. (1983). Pergolide treatment in parkinsonism.. PubMed. 37. 85–94. 5 indexed citations
20.
Lesser, Ronald P. & S Fahn. (1978). Dystonia: a disorder often misdiagnosed as a conversion reaction. American Journal of Psychiatry. 135(3). 349–352. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026